|
ACAT1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.67228511225449E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.71019889758395E-11 |
| Normal-vs-Stage2 |
1.24919999999751E-06 |
| Normal-vs-Stage3 |
1.01669783703073E-11 |
| Normal-vs-Stage4 |
4.63173943643369E-12 |
| Stage1-vs-Stage2 |
6.004600E-01 |
| Stage1-vs-Stage3 |
6.021100E-03 |
| Stage1-vs-Stage4 |
7.68899999999961E-05 |
| Stage2-vs-Stage3 |
9.181600E-02 |
| Stage2-vs-Stage4 |
1.569600E-02 |
| Stage3-vs-Stage4 |
3.822200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.67589991568229E-10 |
| Normal-vs-AfricanAmerican |
1.66630043096916E-11 |
| Normal-vs-Asian |
1.249180E-04 |
| Caucasian-vs-AfricanAmerican |
2.638200E-01 |
| Caucasian-vs-Asian |
3.278800E-01 |
| AfricanAmerican-vs-Asian |
4.087800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.792632874422E-12 |
| Normal-vs-Female |
8.08660000073402E-08 |
| Male-vs-Female |
7.815800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.80739892338988E-11 |
| Normal-vs-Extreme_Weight |
7.75359998428371E-10 |
| Normal-vs-Obese |
1.34680000485332E-08 |
| Normal-vs-Extreme_Obese |
7.877800E-03 |
| Normal_Weight-vs-Extreme_Weight |
4.333800E-01 |
| Normal_Weight-vs-Obese |
3.427600E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.908300E-02 |
| Extreme_Weight-vs-Obese |
8.203200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.306400E-01 |
| Obese-vs-Extreme_Obese |
2.982800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.31450000276467E-08 |
| Normal-vs-Age(41-60Yrs) |
6.84674539286334E-13 |
| Normal-vs-Age(61-80Yrs) |
2.43979999536847E-08 |
| Normal-vs-Age(81-100Yrs) |
8.574400E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.115400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.420100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.060400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.743210E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.088800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.203200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.43625169721918E-12 |
| Normal-VS-Type2 PRCC |
3.94400000436335E-08 |
| Normal-VS-KIRP CIMP |
6.25055562863963E-14 |
| Normal-VS-Unclassified PRCC |
7.52589990327124E-10 |
| Type1 PRCC-VS-Type2 PRCC |
8.248400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.22610000041767E-07 |
| Type1 PRCC-VS-Unclassified PRCC |
1.296190E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.02629999948678E-07 |
| Type2 PRCC-VS-Unclassified PRCC |
1.605800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.803900E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.66189958963992E-10 |
| Normal-vs-N1 |
1.52600154734728E-12 |
| Normal-vs-N2 |
1.63469238145808E-12 |
| N0-vs-N1 |
5.022800E-03 |
| N0-vs-N2 |
5.26760000063575E-08 |
| N1-vs-N2 |
6.499200E-03 |
|
|
